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Abstract
Background: Different immunotherapy approaches for the treatment of cancer and autoimmune diseases are being
developed and tested in clinical studies worldwide. Their resulting complex experimental data should be properly
evaluated, therefore reliable normal healthy control baseline values are indispensable.
Methodology/Principal Findings: To assess intra- and inter-individual variability of various biomarkers, peripheral blood of
16 age and gender equilibrated healthy volunteers was sampled on 3 different days within a period of one month. Complex
‘‘crossomics’’ analyses of plasma metabolite profiles, antibody concentrations and lymphocyte subset counts as well as
whole genome expression profiling in CD4
+T and NK cells were performed. Some of the observed age, gender and BMI
dependences are in agreement with the existing knowledge, like negative correlation between sex hormone levels and age
or BMI related increase in lipids and soluble sugars. Thus we can assume that the distribution of all 39.743 analysed markers
is well representing the normal Caucasoid population. All lymphocyte subsets, 20% of metabolites and less than 10% of
genes, were identified as highly variable in our dataset.
Conclusions/Significance: Our study shows that the intra-individual variability was at least two-fold lower compared to the
inter-individual one at all investigated levels, showing the importance of personalised medicine approach from yet another
perspective.
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Introduction
Advanced therapies of complex diseases such as cancer and
autoimmune disorders are being evaluated in a number of clinical
studies worldwide. The majority of clinical studies provide reports
containing results exclusively related to the groups of patients
involved, segregated according to different treatment protocols,
the efficacies of which are being cross-evaluated and compared. In
many cases historical data are considered for comparison while the
healthy population control values are only used in a very limited
extent or not applied at all [1,2]. Especially when different
immunological parameters are being evaluated such normal
healthy controls are indispensible for proper interpretation of
complex experimental datasets and should therefore be readily
accessible to the research community.
Peripheral blood is the most easily accessible human tissue.
Through analysis of its cellular components as well as numerous
soluble factors, we can assess the (patho)physiological state of the
organism. One of the most promising approaches for its evaluation
are the so called ‘‘omics’’ technologies that enable holistic insight
into studied system [3]. Until now several studies analysing
separate ‘‘omes’’ in peripheral blood that included healthy and
diseased individuals have been performed. Genome-wide tran-
scriptomics studies were performed either on complex mixtures of
blood cells, i.e. peripheral blood mononuclear cells [4,5,6,7] or on
isolated sub-populations of immune cells [8,9,10,11]. Biological
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difficult and may lead to erroneous conclusions. Similarly, artefacts
in measured levels of gene expression can arise as a consequence of
lasting ex vivo cell-isolation procedures, leaving relatively low
number of older datasets for correct biological interpretations
[12,13,14,15]. Metabolomics was shown to have a huge potential
in investigation of physiological state, diagnosing diseases and
measuring responses to various treatments [16,17,18,19,20]. While
in metabolomics the idea of multiplex markers is already
implemented, the studies which integrate data from several omics
platforms are still very rare [21].
There are numerous reports showing that age, gender, ethnicity,
diet and stress influence the numbers and functionalities of
different immune cells, levels of antibodies and concentrations of
bioactive factors that can be detected in peripheral blood samples.
For example, in general, women are more efficient in mounting
strong immune responses to infection than men, but are at the
same time also more prone than males to suffer from autoimmune
diseases, such as multiple sclerosis, rheumatoid arthritis and
systemic lupus erythematosus [22]. Ageing is a physiological
process that declines the percentages and functions of various types
of immune cells, differently affecting males and females [23,24,25].
Nutrition can also cause functional changes in certain immune
processes. For example, nutrition-related disorders such as
anorexia and bulimia, as well as overweight (BMI 25.0–29.9)
and obesity (BMI.30) are able to affect cellular, as well as
humoral immune responses [26].
For a reliable clinical evaluation of complex molecular
signatures it is especially important to carefully examine the
physiological variability of all markers. Here we present a pilot
study on 16 healthy individuals, applying combination of
transcriptomics, metabolomics and cell biology tools in order to
evaluate physiological variability of different peripheral blood
measurables. We have focused on populations of several
lymphocytes subtypes which we considered to be the most relevant
for monitoring the effectiveness of novel cell-based immunother-
apies of cancer. For gene expression studies in particular, isolated
CD4
+ T and natural killer (NK) cells were chosen, as the first ones
are crucial for the induction and regulation of antigen-specific
cellular and humoral adaptive immune responses and the second
ones having important ‘‘missing self’’-based and antibody-
dependant cytolytic functions within innate immunity. The
variability of different markers was evaluated in relation to sex,
age, body mass index (BMI) and a day-to-day variance. Special
care was taken to assure the correct experimental setup and to
synchronise sampling and sample processing for all technological
platforms used thereby avoiding sampling-related artefacts.
Methods
Blood sampling from healthy volunteers
This study was approved by the National Ethics Committee
(Document No. 149/05/08). Peripheral blood samples were
drawn from 16 healthy individuals after obtaining their signed
informed consents. The selected experimental group was age and
gender equilibrated (text S1). BMI was calculated for each
individual enrolled. The inclusion criterion was age (20–60 years).
The exclusion criteria were the following: acute or chronic
diseases, pregnancy, smoking and taking oral contraception or
other drugs. Every volunteer was screened for the viral and
bacterial infection markers of blood-transmittable diseases (syph-
ilis, HIV, hepatitis B and hepatitis C). Fasting morning blood
samples were collected from each participant between 7 am and 9
am, on three separate days within a period of one month. Each
time 43 ml of peripheral blood was drawn into three different
types of Vacutainer tubes (BD Biosciences). For that purpose three
8 ml CPT, containing sodium chloride solution, two 8 ml
K2EDTA and one 3 ml EDTA tubes were used. Blood samples
were then immediately processed for isolation of selected
lymphocyte subsets and a subsequent flow cytometry analysis, as
described later. A basic haemogram analysis was also performed.
Individuals were marked with a letter P (P as proband) and
consecutive numbers, i.e. from P1 to P16. As blood samples from
the individual P11 did not pass the threshold of normal cell counts,
another healthy volunteer (P17) was selected and included into the
study group. Blood samples of each individual were additionally
labelled in order to distinguish between the 3 different sampling
times, e.g. P1_D1, P1_D2, P1_D3 (D as day).
Metabolite profiling
For the metabolite profiling analysis, lipid and polar fractions
were extracted from plasma samples and subjected to gas
chromatography coupled with mass spectrometry (GC-MS) and
liquid chromatography coupled to tandem mass spectrometry
(LC-MS/MS) analysis, respectively. Prior they were analysed by
GC-MS, the samples were sequentially derivatised, while for LC-
MS/MS analysis a technology allowing high sensitivity multiple
reactions monitoring was applied. For the assessment of
catecholamines and steroids, separate sample preparations and
MS analytical approaches were performed, proprietary to
Metanomics Gmbh, which carried out all metabolomics proce-
dures. A schematic overview of the metabolite profiling analysis
procedures is presented within the Text S1. A reference sample
was prepared from all 48 plasma samples for a relative
quantification of data. Only those measured values that were
above the reliable quantification threshold limit were treated
quantitatively and the rest of them only qualitatively. Data that
were considered as quantitative were normalized against the
reference sample and log10-transformed.
Lymphocyte subpopulation counting
The expression of cell antigens was measured on lymphocytes
from fresh whole bloodcollectedintoEDTA Vacutainer tubes. One
hundred ml of peripheral human blood were incubated with 20 mlo f
CD25 FITC, CD4 PerCP, CD69 FITC, CD16 PE, HLA-DR PE
and CD8 PerCP (all BD Biosciences) for 20 min at room
temperature in a dark. Erythrocytes were lysed by incubation for
10 min with BD FACSTM Lysing Solution (BD Biosciences).
Samples were centrifuged for 5 min at 450 g and subsequently
washed twice with a cold phosphate-buffered saline (PBS). Cell
pellets were then resuspended in 1 ml PBS. A total of 10000 events
were collected. At least 2000 viable cells were gated and analyzed in
eachtest.Lymphocytes werecharacterised byFSCvs. SSC followed
by gating on CD4, CD8 and CD16 expression. Cell acquisition was
performed using a BD FACSCanto flow cytometer. FlowJo version
7.6.1 (TreeStar) was utilized to analyze the percentage of CD25hi
CD4+, HLA-DR+CD8+ T cells, and CD69+CD16+ NK cells.
Isolation of CD4
+ T and NK cells
Peripheral blood from each nine 8 ml Vacutainer CPT tubes (3
tubes/individual/sampling day), was processed according to the
manufacturer’s instructions to obtain a layer of mononuclear cells
(MNCs) above the gel. The resulting MNCs from each CPT tube
were transferred into a new separate container, gently mixed with
the PBS buffer and then centrifuged for 10 min at 300 g at room
temperature. The supernatants were discarded and the remaining
MNC pellets were re-suspended, each in a 200 ml of PBS,
supplemented with 2% foetal bovine serum (FBS) and 1 mM
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triplicate MNC suspensions, pertaining to the same individual,
whose blood was taken on a defined sampling day, was subjected
to positive selection of CD4
+ T cells by using the EasySepH
Human CD4 Positive Selection Kit (Stemcell Technologies). The
remaining MNC suspension was used for positive selection of NK
cells with the EasySepH Human CD56 Positive Selection Kit
(Stemcell Technologies). Both cell selection protocols were carried
out according to the manufacturer’s instructions. The isolated cells
were immediately frozen and kept at 280uC until total RNA
extraction. Prior to that, a small fraction of cells was removed,
trypan blue stained for their vitality and counted in a Bu ¨rker-Tu ¨rk
counting chamber using an inverted optical microscope. The
whole procedure was performed in less than 1 hour to minimise
the stress related effects in transcriptomics datasets.
Isolation and quality control of total RNA
Total RNA was extracted from isolated CD4
+ T and NK cells
with the RNeasy Mini Kit (Qiagen) according to manufacturer’s
instructions. Genomic DNA was removed by adding DNase I
(Invitrogen) and RNA samples were concentrated with the
RNeasy miniElute Cleanup Kit (Qiagen), as prescribed by the
manufacturer. The quality and quantity of each total RNA sample
was assessed with a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies) and the Agilent 2100 Bioanalyzer
(Agilent Technologies).
Microarray hybridizations and data preprocessing
The isolated RNA samples were first labelled with Illumina
TotalPrep RNA Amplification Kit (Ambion) and subsequently
hybridized to HumanWG-6 v3 Expression BeadChip (Illumina).
After scanning, image acquisition was carried out with the
BeadStudio version 3.3.7 software (Illumina).
Data preprocessing was performed in a R statistical environ-
ment [27], using the lumi software package for data input, quality
control and robust spline normalization on log2-transformed data.
According to quality control, pair-wise MA plots, density plots of
signal intensity, as well as box plots were analysed for each
microarray, both on raw and normalised data. In order to reduce
the extent of false positive results, unexpressed genes with a
detection p-value above 0.01, were filtered out in a subsequent
data preprocessing step. For probe annotation, annotate, lumiHu-
manAll.db and GO.db Bioconductor software packages were used.
Quantitative real-time PCR
TaqMan MGB
TM dual-labelled probes (AssayOnDemand,
Applied Biosystems) were used for real-time PCR analysis of the
following selected genes: gamma 1 actin (ACTG1), adenylate
cyclase-associated protein 1 (CAP1), coiled-coil-helix-coiled-coil-
helix domain containing 2 (CHCHD2), glutathione S-transferase
theta 1 (GSTT1), eukaryotic translation initiation factor 1A, Y-
Figure 1. Overview of the experimental design. Sixteen gender and age matched healthy individuals were enrolled in a study. Fasting morning
blood samples were taken on three days within one month and analysed using different omics approaches. Fasting morning samples were collected
from 16 volunteer three times within a one month period.
doi:10.1371/journal.pone.0028761.g001
Figure 2. Overview of metabolite profiles variability found in
plasma samples of healthy volunteers by principle component
analysis score plot. Triangle – male volunteer, circle – female
volunteer, coloured according to volunteers, labels shows sampling
number within one volunteer. PC - principal component.
doi:10.1371/journal.pone.0028761.g002
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granulysin (GNLY), interleukin 7 receptor (IL7R), DR beta 1
major histocompatibility complex, class II (HLA-DRB1) and DO
beta major histocompatibility complex, class II (HLA-DOB). Two
standard endogenous reference controls were also included, i.e.
actin beta (ACTB) and 18S ribosomal RNA gene (18S). The
cDNA synthesis, the qPCR reactions and data analysis were
performed as described previously [28].
Antibody concentrations
Antibody concentrations were determined with the Human IgG
and IgM ELISA Quantification Set (Bethyl Laboratories) in 96
well high binding plates (Costar). Plasma samples were diluted
with a blocking buffer as follows: 1:1000 for IgM and 1:10000 for
IgG determination. The ABTS Single Solution (Zymed) was used
for detection.
Statistical analyses
All datasets were first visualised by principal component (PCA)
and hierarchical clustering analysis (HCA) to overview the sample
variability, using Multiexperiment Viewer software [29] (MeV).
In the metabolomic dataset a mixed model analysis of variance
with biological factors, i.e. gender, BMI and age, up to the second
order of interactions was applied. The sample age and time of
sampling were considered as additional factors. Sample age, time
of sampling, BMI and volunteer age were coded as numerical
predictors and the gender as categorical one. Random effects were
included in the model to take into account the variability of
specific metabolite levels between individuals (SDsubject) and to
compare them to technical and intra-individual variability
(SDresidual). The ontology enrichment analysis was performed
using Fisher’s exact test.
Statistical testing (one-way ANOVA or t-test) of gender, age and
BMI influences on the transcriptomics, flow cytometry and
antibody concentrations datasets was performed using MeV
[29]. Testing groups were defined to take into account the known
physiological data and to ensure correct statistical analysis. For the
latter, balanced number of samples in compared groups were used.
Accordingly, 3 groups were formulated to assess the influence of
age (,30, 30$age#50 and .50) and 3 for testing the BMI-related
effects (lean: BMI,23, normal: 23$BMI#27, overweight:
BMI.27) thereby creating equally represented clusters for
statistical comparisons. Differentially expressed transcripts
(p,0.01, logFC(abs).0.85, FC – fold change) were functionally
analysed according to Gene Ontology (GO), Kyoto Encyclopaedia
of Genes and Genomes Onthology (KEGG) Pathways, Reactome
Pathways and chromosome localization within the SystherDB
toolbox [30], using Fisher’s exact test. False discovery rate (FDR)
multiple testing correction of p-values was applied where indicated
[31]. To assess the physiological variability of gene expression
within our group of healthy individuals, coefficients of variation
(CV) in expression values were calculated over all analysed
samples and R statistical environment [27]. Separately, the
variability in gene expression was also estimated in samples
collected from the same individual on three different days.
Results
Fasting morning samples of sixteen healthy volunteers were
analysed in a ‘‘crossomics’’ study of the physiological variability.
Blood samples from each volunteer were taken on three different
days during a month period to assess the variability of markers in a
single individual. Measurements of metabolites, concentrations of
IgG and IgM antibodies, lymphocyte subset counts and gene
expression in two selected immune cell types, namely CD4
+ T cells
Table 1. The ontology enrichment analysis of metabolites that were identified as gender, age and BMI related or were identified
as highly variable (HV, CV.0.5) in the analysed healthy population subset.
Ontology ALL Gender BMI Age Variability
Amino acids and related 32 0.00 (24) ns (2) ns (5) ns (2)
Phospholipids 20 ns (6) ns (6) 0.03 (6) ns (0)
Fatty acids 20 0.02 (1) ns (2) ns (1) 0.00 (9)
Cholesterol, bile acids, fatty alcohols and related 7 ns (0) ns (1) ns (0) 0.02 (4)
Steroids and related 8 0.03 (5) ns (3) ns (2) 0.00 (6)
Total no. of DP/HV metabolites P,0.05 35 33 29 39
:male 45 30
:female 20 21
Total number of differentially present (DP) metabolites (p,0.05) related on gender, age, BMI, BMI within male individuals, age within male volunteers (:male), BMI within
female volunteers and age within female volunteers (:female) are also given. Fisher’s exact test was used to calculate significance of ontology enrichment (p-value is
reported; ns – not significant). ALL - all metabolites within the ontology group. Number of differentially present metabolites in each category is given in brackets within
each category.
doi:10.1371/journal.pone.0028761.t001
Figure 3. Average concentrations of two soluble sugars,
glucose and mannose, are significantly increased in plasma
samples of healthy volunteers with higher BMI values.
pGlucose=0.0014, pmannose=0.0001. Error bars represent standard error
within monthly measurements.
doi:10.1371/journal.pone.0028761.g003
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representing healthy population (Fig. 1).
Metabolite profiles in blood plasma samples of healthy
volunteers
Altogether 243 metabolites were identified and quantified from
the collected plasma samples, 160 of them with a known structure
and 83 still pending for their final structural identification. The
acquired metabolite profiling data were analysed on two levels. A
multivariate data overview was generated using principle compo-
nent analysis (PCA) and hierarchical clustering analysis (HCA).
Further, the effects of gender, age and BMI on metabolic profile of
individuals were evaluated using statistical testing.
The PCA revealed high similarity of samples collected from the
same individual on different days (Fig. 2). Using combination of
PC1 and PC2 male and female samples separated, which indicates
a strong impact of gender on metabolite profiles. These
observations were confirmed also by the HCA (Text S1).
Mixed-effects model analysis of variance was performed to
acquire the information on effects of gender, age and BMI on the
metabolite profiles in collected samples. Gender was found to have
the strongest effect on plasma metabolite profiles, followed by BMI
and finally the age (Table 1, Table S1). The ontology enrichment
analysis showed that statistically significant gender-attributed
differences are mainly in amino acids, phospholipids and steroid
hormones concentrations (Table 1). The highest difference in
metabolite levels was detected for testosterone, being 14-fold
higher in males than in females. Significantly higher values in
males compared to females were also found for testosterone-17-
sulfate, androstenedione and adrenaline. Similarly, levels of 9
amino acids (methionine, cysteine, isoleucine, leucine, proline,
ketoleucine and indole-3-lactic acid) and several lipids (eicosapen-
taenoic acid, lysophosphatidylcholines C18:2 and C18:1) were
found to be significantly higher in males, with more than 20%
differences in their concentrations detected.
The levels of hormones were also found to be dependent on age
and BMI, especially the ones belonging to the group of steroids
and catecholamines (Table 1, Table S1). For example, andro-
stenedione was decreasing with both age and BMI (Text S1). The
most prominent group of metabolites detected through the
ontology enrichment analysis that increased both with age and
BMI, were however the lipids. Only phospholipids were found to
be significantly regulated with age, app. 20% higher measured
concentrations of lysophosphatidylcholine 16:0 and phosphatidyl-
choline in older volunteers. Higher levels of sphingolipids,
cholesterol, some fatty acids and glycolipids are also associated
with higher BMI. In addition the increase in two soluble sugars,
glucose and mannose, was associated with higher BMI values
(Fig. 3).
In parallel, reliable estimates of residual, i.e. technical and intra-
individual variability (SDresidual), as well as inter-individual
standard deviations (SDsubject), were determined for 218 out of
243 metabolites. On average, SDsubject and SDresidual values
were of similar size. However, few individual metabolites,
metanephrine, normetanephrine, 3,4-dihydroxyphenylalanine
Figure 4. Variability of different lymphocyte subsets cell
counts and antibody concentrations assessed in blood samples
of healthy individuals. The HCA was performed both, for the analysis
of samples and the variation of each parameter. The colour scale
denotes increasing cell counts/concentrations of the measured
parameters, with both extremes being low (blue) and high (yellow).
The total numbers of leukocytes (WBC), lymphocytes (LYM), natural
killer cells (NK), CD8
+ and CD4
+ T lymphocytes and their activated forms
(aNK, aCD8
+ T, aCD4
+ T), were determined by flow cytometry. The
concentrations of IgG and IgM antibodies are also included. Samples
are marked by consecutive number of volunteer (P1–P17), volunteer
gender (F, M) and sampling day (D1–5).
doi:10.1371/journal.pone.0028761.g004
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higher SDresidual in comparison to SDsubject values.
Variability of metabolites in healthy population was further
evaluated by comparing coefficients of variability (CVs). Forty-one
metabolites were identified with CV higher than 50% and 95 with
CV higher than 30%. In ontology enrichment analysis, beside a set
of lipids like cholesterol and different fatty acids, steroid hormones
and some catecholamines, were additionally identified to be highly
variable. Different xenobiotics, like coenzyme-Q, a-tocopherol,
salicylic acid, caffeine, hippuric acid and others related to specific
diet intake were also found to be variable (table 1).
Fluctuations in lymphocyte subpopulations and antibody
levels
Besides the numbers of total leucocytes, lymphocytes, NK cells
(CD16
+), cytotoxic CD8
+ and CD4
+ T cells that were determined
in collected samples, the counts of activated forms of the same cell
types (CD16
+CD69
+, CD8
+HLA-DR
+ and CD4
+CD25
+) were
assessed by flow cytometry. In parallel, levels of IgG and IgM
antibodies were measured in blood plasma samples.
Similar as in metabolite profile analysis, the intra-individual
variability was smaller than inter-individual one as shown by
mulitivariate data analysis (Fig. 4). Statistical analysis of cell counts
and antibody concentrations showed that the numbers of NK cells
and their activated counterparts are gender-related (pNK=0.002,
pactNK=0.001) with more than 50% higher cell counts determined
in women. The count of activated CD4
+ T cells were similarly
more than 50% higher in women (p=0.008). Interestingly, when
studying the influence of BMI, only the CD4
+ T cell counts were
found to decrease significantly with increasing BMI (20%
decrease, p=4.6610
28). In addition, the levels of CD8
+ T
subtype cell counts were found to decrease for 30% with age
(p=0.0003), while the percentage of activated CD8
+ T cells
increased two-fold in older individuals (p=0.0004, Text S1, Table
S2).
Variability of gene expression in NK and CD4
+ T cells
The transcriptomes of NK and CD4
+ T cells were analysed
separately, using whole genome microarrays (GEO Acc.
No. GSE26163). We have focused on gene expression profiling
of two selected lymphocyte subtypes instead of a more common
and less tedious transcriptomics profiling of the whole lymphocyte
population. The transcriptome profile of cell population depends
both on the gene expression in each individual cell type as well as
on the proportions of cell types and therefore contains biologically
less relevant information compared to analysis of transcriptomes of
separate cell types. When setting up the experimental design,
special attention was given to sampling and sample processing in
terms of minimizing the duration and standardizing the sample
processing. All peripheral blood samples were processed in less
than 1 h following their collection as it has been reported that
within this time frame the sampling related stress response is not
triggered yet [12,32]. The variability in individual gene expression
was analysed by multivariate methods (HCA, PCA) for both, the
NK and CD4+ T cell data sets. The physiological variability of
gene expression in healthy volunteers was assessed by considering
CV as its measure.
Altogether, 19746 transcripts were statistically significantly
detected above background levels in NK and CD4
+ T cell types.
Similarly as in the case of metabolite profiling, the cell counting
and antibody analysis, the multivariate overview showed that the
intra-individual variability is smaller than the inter-individual one
(Fig. 5, table 2). Some individual samples formed separate clusters
in HCA (Text S1). These samples were compared to those,
deviating from standard behaviour in case of IgG concentrations
and percentages of both activated cell types. No sample
overlapping was identified indicating that these differences were
not due to the activation of each particular individual’s immune
system, at any of the sampling times.
The percentage of highly variable transcripts was in both cell
types below 10% (Table 2). Functional analysis of these transcripts
showed that the most variable pathways are related to signalling
(Text S1). Several immune related signalling pathways were
identified as variable both in CD4
+ T and NK cells, like Toll Cell
Receptor related signalling, generation of second messenger
molecules, cytokine signalling. Other interesting processes identi-
fied to be highly variable between healthy individuals were
processes related to platelet aggregation and apoptosis. On the
other hand, several pathways identified as highly stable are in both
cell types related to transcription and translation, metabolism of
glucose and energy metabolism.
Further, the gene expression variability within each of the
volunteers during the sampling interval was evaluated (Fig. 5).
Overall, all individuals had similar distribution of variability in
gene expression, no major discrepancies were detected. One point
to be noted however is that intra-individual variability (median CV
app 0.1) is much lower than total variability in gene expression
(median CV app. 0.2) as was also indicated by multivariate testing.
Additionally, we checked if the same genes were identified as
variable in different individuals. The pattern of genes with variable
day-to-day expression (CV.0.5) seems to be in majority
individuum-specific (Fig. 6).
Physiological impacts on genes expression in CD4
+ T and
NK cells
Statistical models to test and assess the effects of gender, age and
BMI on the gene expression profile were applied. Overall,
remarkably low number of differentially expressed (DE) transcripts
was identified (Table 3). Individual inspection of DE transcripts
Figure 5. Intra-individual variability in gene expression compared to inter-individual variability. Variabilities are represented as
boxplots of gene expression CV for each individual and in complete dataset. A) CD4
+ T and B) NK cells. For subject P9 this evaluation was not possible
for CD4
+ T cell dataset as only one sample out of the three passed the technical quality control in all steps of the procedure. The same was true for
subjects P9, P13 and P12 in NK cells dataset.
doi:10.1371/journal.pone.0028761.g005
Table 2. Percentage of transcripts with high and low
variability was determined.
Cell type High variability (CV.0.5) Low variability
Inter Intra (avg) Intra (max) (CV,0.1)
CD4
+T 4.1% 1.8% 4.5% 1.7%
NK 7.5% 2.3% 6.9% 2.2%
In parallel to the percentage of transcripts with high inter-individual variability
(inter), percentage of transcripts with high variability within individual in
monthly measurements were also calculated (intra); average percentage
(intra(avg)) and maximum (intra(max) percentage of highly variable genes
within 16 studied individuals are given. CV – coefficient of variability.
doi:10.1371/journal.pone.0028761.t002
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x and y chromosomes, except GPR128, coding for the G-protein
coupled receptor, which is located on chromosome 12. A non-
protein coding X (inactive)-specific transcript (XIST) was the only
gene with stronger expression in female volunteers, both in CD4
+
T and NK cells. Several interleukine receptor genes, most
prominently IL23R and IL7R, were found to be down-regulated
with increasing BMI in NK cells (Fig. 7). The opposite was true for
two defensin genes (DEFA1, DEFA3) which were both up-
regulated with increased BMI in NK cells, with only DEFA3 being
increased also in CD4
+ T cells. In CD4
+ T cells strong down-
regulation of HLA-DOB gene, coding for the particular human
leukocyte antigen (HLA) class II beta chain paralogue, was also
detected with the increased BMI (Fig. 7). GPR128, insulin-like
growth factor binding protein 3 (IGFBP3) and urotensin 2 (UTS2)
genes were up-regulated in CD4
+ T cells with the increasing age.
The G-protein coupled receptor GPR128 was identified as DE as
it was expressed only in one out of three samples in two individuals
in NK cells (P10_D5, P12_D3) and only in one individual in CD4
+
T cells (samples P12_D3, P12_D4, P12_D5). No particular
characteristics of these samples were identified in other datasets
collected, e.g. in either lymphocyte cell counts, immunoglobulin
concentrations, metabolite or gene expression profile.
Verification of microarray results by real-time PCR
Genes identified to have either very low expression variability in
both, CD4
+ T and NK cells (ACTG1, CAP1, CHCHD2), high
expression variability in both cell types (HLA-DRB1, GSTT1,
EIF1AY) or high expression variability exclusively in CD4
+ T
(GIMAP7) or NK cells (GNLY), were chosen for the confirmatory
qPCR analysis. In addition, two BMI-related genes, the first
expressed in NK (IL7R) and the second in CD4
+ T cells (HLA-
DOB), were also included. Expression profile of selected genes
determined by qPCR showed the same patterns as determined by
DNA microarray hybridisations (supplemental data).
Discussion
Novel immunotherapy approaches aiming especially at the
treatment of cancer are becoming more and more promising. As
there are numerous ongoing clinical studies and those still to be
initiated which are testing the safety and effectiveness of such
advanced therapies, there is a need for relevant and reliable
control baseline values of different biological markers. The use of
such controls would enable revealing of highly predictable, stable,
robust and easy accessible diagnostic/prognostic markers.
Our study indicates that numerous blood measurable markers
are remarkably stable. Within our healthy population sample, app.
20% of plasma metabolites and below 10% of genes expressed in
NK and CD4
+ cells respectively, had high variability in measured
levels and would therefore most probably not be appropriate as
clinically applicable diagnostic/prognostic markers. However,
some of these variable determinants could still have some
diagnostic or prognostic potential, especially if used in a
combination with other markers, thereby forming a more complex
and predictable molecular signature. The extent of intra-
individual variability was found to be on average about half of
the inter-individual one on all investigated levels, indicating the
advantages for the so called personalised medicine strategies.
However, certain metabolic substances, such as sex hormones
catecholamines and glucocorticoids as well as some lipids, had
higher intra-individual variability compared to the inter-individual
one. This phenomenon can be attributed either to specific
individual diet intake on or close to a particular sampling day
and to highly variable endogenous, prevalently hormonal
anabolism and catabolism in each individual, also reflecting his/
her particular reactions to physical and psychical stressors.
Expectedly, different xenobiotics, prevalently related to specific
diet intake, were also characterised as highly variable.
While age, gender and ethnical influences are practically always
accounted for in similar studies, other factors, like BMI and stress,
being powerful players, able to harness the homeostasis of the
human organism, are often not. Obese individuals experience
chronic low-grade systemic immune activation accompanied by
inflammation, which can be attributed to interactions between
adipose tissue and immunocompetent cells [33]. Consequently, in
obese individuals, increased incidence and severity of certain
infectious diseases and occurrence of poor antibody responses to
antigens, as compared to lean individuals, are observed [26,34].
One however needs to note that the majority of studies analysing
effects of obesity on immune responsiveness have been performed
on morbidly obese individuals with BMI.50, while in our study,
only four healthy individuals with BMI values between 27 to 30,
were evaluated. The levels of certain cytokines, especially IL-6 and
TNF-a, were found to be increased in subjects with high BMI
values [35]. We did not measure levels of specific cytokines,
however, we detected the decrease in transcription of two cytokine
receptor genes, namely IL7R and IL23R in NK cells of healthy
but overweight/obese volunteers (Fig. 7, supplemental data). This
might be an interesting aspect to explore in studying effects of
obesity. IL7R is involved in enhancement of NK cell maturation
and survival [36] and is genetically associated with susceptibility to
autoimmune diseases, especially multiple sclerosis [37]. IL23R has
an impact on the activity of NK and especially Th17 cells [38] and
may participate in acute response to infection in peripheral tissues
as well as in certain autoimmune diseases, like morbus Chron [39].
Our finding that HLA-DOB gene is strongly down-regulated in
CD4
+ T cells with the increasing BMI is interesting and should be
Figure 6. The pattern of transcripts with variable day-to-day expression seems to be in majority individuum-specific. Distribution of
transcripts with high day to day variability in expression among healthy individuals for A) CD4
+ T, and B) NK cells is shown. Transcripts identified as
highly variable (CV.0.5) in at least one individual are ordered in rows of the heat map (1952 transcripts for CD4
+ T and 2635 transcripts for NK cells).
Individuals included in our study are listed in columns. Grey colour – the transcript was not identified as highly variable in the particular volunteer.
Black colour – the transcript was identified as highly variable in particular volunteer.
doi:10.1371/journal.pone.0028761.g006
Table 3. Number of genes with sex, age or BMI-related
expression in CD4
+ T and NK cells.
CD4
+ T cells NK cells
Gender 38 (17) 111 (17)
Age (,30 versus .50) 158 (9) 89 (5)
BMI (,25 versus .27) 73 (3) 1907 (52)
The cutoff for statistical significance was p,0.01. Numbers of differentially
expressed (DE) genes with p,0.01 and relative log2 expression ratio between
20.85 and 0.85 is given in brackets. The overrepresentation analysis identified
DE genes in the GO, KEGG and Reactome pathway ontologies did not produce
any significant results.
doi:10.1371/journal.pone.0028761.t003
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presence of HLA-DO in T lymphocytes, showing that only weak
DOB mRNA transcript expression can be detected in these cells
[40]. Namely, HLA-DO molecules are expressed intracellularly,
within the pre-lysosomal and lysosomal HLA-DR-containing
compartments, prevalently in B lymphocytes and dendritic cells
[40]. On the other hand defensin genes were found to be induced
in individuals with higher BMI which is in agreement with the
hypothesis that obese individuals experience continuous low grade
systemic immune activation [33]. As one would expect, due to
higher caloric input and a probable insulin resistance, the
concentrations of certain lipids, glucose and mannose were also
increased in individuals with higher BMI values (Fig. 3).
In general, our analysis reflects well-known effects of age as well
as gender-related differences in basal anabolism and catabolism.
Men have a higher muscle-to-fat ratio and they experience more
extensive basal metabolic rate compared to women [41]. While
sex- and stress-related hormones, some amino acids and most of
the differentially present lipids were present in higher concentra-
tions in males, those of phosphatidylcholine, creatine and taurine
were found to be higher in females (Table 1), which is consistent
with previous reports [42,43,44]. Expectedly, besides BMI, the age
Figure 7. The most prominent BMI-related changes in gene expression were found for interleukin 7 receptor (IL7R), insulin-like
growth factor binding protein 3 (IGFBP3), defensin 3 (DEFA3) and DO beta major histocompatibility complex, class II (HLA-DOB).
CD4
+ T cells - open squares, NK cells - closed circles. Error bars represent intra-individual standard error.
doi:10.1371/journal.pone.0028761.g007
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steroids and catecholamines (Table 1), as reported in previously
published observations [45]. Gender- and age-related differences
were also detected in cell counts of NK, CD8
+ T lymphocytes and
their activated counterparts. Higher activated NK and CD4
+ T
cell counts were found in women (supplemental data). In addition,
the cell counts of both types of CD8
+ T cells, but not CD4
+ or NK
cells were found to decrease with age (supplemental data), which is
concordant with the existing data [46]. Interestingly however,
almost no gender- or age-related differences were detected in gene
expression profiles of CD4
+ T and NK cells (supplemental data).
Two diabetes related genes, coding for insulin-like growth factor
(IGFBP3) and urotensin 2 (UTS2), were increasingly expressed
with age which might indicate inclination of some individuals
towards the development of type 2 diabetes. We are planning to
monitor the health status of those in question and check if diabetes
might evolve in the upcoming years.
This is the first ‘‘crossomic’’ study performed measuring
variability of different components in peripheral blood of healthy
Caucasoid individuals. Overall, the distribution of measured
values in our dataset was in agreement with previously published
data, providing that such information already existed, regardless of
the fact that our sample of healthy individuals was rather small.
The determined physiological baseline values for measured
peripheral blood components can thus assist in development of
effective diagnostics, prognostics and evaluation of responsiveness
to various types of therapies by using complex molecular
signatures biomarkers. Low intra-individual variability of different
markers compared to the inter-individual one was measured on all
investigated levels which indicates the importance of personalised
medicine approaches from another perspective.
Supporting Information
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odological approaches as well as some bioinformatics
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